Washburn, W N <br/><br/>
Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  Aug 2007 
 - 4290-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0960-894X 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2007.05.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-3 Receptor Agonists<br/>Adrenergic beta-Agonists--chemistry<br/>Alkylation<br/>Oxidation-Reduction<br/>Propanolamines--chemistry<br/>Structure-Activity Relationship